Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Cost of Revenue (2016 - 2025)

Haemonetics has reported Cost of Revenue over the past 17 years, most recently at $136.6 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 11.88% year-over-year to $136.6 million; the TTM value through Dec 2025 reached $535.9 million, down 16.5%, while the annual FY2025 figure was $611.9 million, 0.91% down from the prior year.
  • Cost of Revenue for Q4 2025 was $136.6 million at Haemonetics, up from $132.6 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $167.4 million in Q1 2024 and troughed at $117.4 million in Q4 2021.
  • A 5-year average of $140.6 million and a median of $141.4 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: grew 20.95% in 2022 and later decreased 19.91% in 2025.
  • Year by year, Cost of Revenue stood at $117.4 million in 2021, then increased by 24.91% to $146.6 million in 2022, then rose by 8.04% to $158.4 million in 2023, then fell by 2.14% to $155.0 million in 2024, then dropped by 11.88% to $136.6 million in 2025.
  • Business Quant data shows Cost of Revenue for HAE at $136.6 million in Q4 2025, $132.6 million in Q3 2025, and $129.2 million in Q2 2025.